Clinical trial
Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients
NCT00122668 · French National Agency for Research on AIDS and Viral Hepatitis, Other · Terminated
Key facts
| NCT number | NCT00122668 |
|---|---|
| Title | Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients |
| Official title | Randomized Comparative Study Evaluating the Rate of Occurrence of a Lipoatrophy Syndrome in ARVnaive HIV-1 Infected Patients Receiving NRTI-Sparing Antiretroviral Regimen (Hippocampe - ANRS 121) |
| Lead sponsor | French National Agency for Research on AIDS and Viral Hepatitis, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections, HIV-Associated Lipodystrophy Syndrome |
| Intervention type | Drug |
| Interventions | non-nucleoside reverse transcriptase inhibitors, nucleoside reverse transcriptase inhibitors, protease inhibitor |
| Enrollment | 112 |
| Start date | Nov 1, 2003 |
| Completion | Jul 1, 2005 |
| First posted | Jul 22, 2005 |
| Last update posted | Nov 15, 2005 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: